Core Viewpoint - The company has received a renewed Drug Production License from the Hunan Provincial Drug Administration, ensuring its continued operations until November 6, 2030 [1]. Group 1: License Information - The new Drug Production License is valid until November 6, 2030, with the license number 湘20150132 [1]. - The company is authorized to produce a variety of pharmaceutical forms, including large volume injections, small volume injections, tablets, hard capsules, granules, syrups, tinctures, and traditional Chinese medicine preparations [1]. Group 2: Company Impact - The renewal of the Drug Production License is a routine procedure due to the expiration of the previous license, and it does not have a significant impact on the company's performance [1].

Core Viewpoint - The company, Hainan Shuangcheng Pharmaceutical Co., Ltd., has successfully obtained a renewed Drug Production License, ensuring its continued operations without significant impact on its business activities [1][2]. Group 1: License Details - The new Drug Production License is valid until August 7, 2030, replacing the previous license that was set to expire on November 5, 2025 [1]. - The company is located at No. 16, Xingguo Road, Xiuying District, Haikou City, with a social credit code of 9146000072122491XG [1]. - The license covers the production of small-volume injections, lyophilized powder injections, raw materials, and large-volume injections [1]. Group 2: Management and Oversight - The legal representative of the company is Wang Chengdong, with Li Jianming as the responsible person and Li Yuan as the quality manager [1]. - The daily supervision and management are conducted by the Hainan Provincial Drug Administration [1].